Vitalgenics sources mesenchymal stem cells (MSCs) that originate from donated umbilical cords via our laboratory partner. In researching MSCs, you will find they possess the highest concentrations of nucleated cells capable of continually creating growth factors and related proteins. These growth factors and proteins play a large part in the potency of the stem cells.

Yes, and yes. The stem cells sourced by Vitalgenics are derived from umbilical cord blood that would normally be discarded after the delivery of a baby. Neither the baby nor the delivering mother is harmed in any way. Many of the controversies surrounding ‘stem cells’ relates to embryonic stem cells (see our guide to different stem cell types). Vitalgenics does not source or endorse the use of embryonic stem cells.

Absolutely. Especially in the realms of pain management and orthopedics. Dozens of treatments have shown tremendous benefit to a multitude of different conditions, diseases, and disorders. See more details about conditions and treatments.

Stem cell treatments where the patient receives stem cells from a source other than their own tissue are called non-autologous. Non-autologous treatments are not ‘approved’ by the FDA, but regulated by them. The FDA has placed the responsibility of these treatments in the hands of practitioners who make the determination of whether the treatments are safe and clinically useful for the patient.

For the most part, Regenerative Medicine procedures and treatments are not covered by typical medical insurance. In certain instances, there may be parts of a surgery related to the Regenerative Medicine procedure that a given insurance company may cover. The general rule of thumb though is that most Regenerative Medicine procedures are considered a “self-pay” or “fee-for-service” procedure. Inquire with a Vitalgenics Practitioner to learn about some of our available financing options.